Originally posted February 2018

Look out Rheumatoid Arthritis and Lupus, Betty Diamond, Peter Gregersen, and the NIH are out to get you.  “The research conducted in Phase I of this program focused on single cells, so we could tease out the contributions of specific pathways inside these cells that may play a role in lupus or rheumatoid arthritis, providing a new approach to understanding autoimmunity.”

“This pioneering program seeks to speed the development of new ways to combat a range of devastating diseases that affect millions of people,” said National Institutes of Health Director Francis S. Collins, MD, PhD. “AMP RA/SLE is entering an exciting phase as experts around the world will begin to mine this invaluable biomedical resource in search of tomorrow’s cures.”

Feinstein Institute, NIH release first datasets to accelerate therapies for arthritis, lupus.